ghk-cu recommended dosage human studies Guide: Typical Protocols, Injection & Topical ghk-cu peptide dosage for humans

doi:10.2174/1381612826666200406152147 Jafari T, Fallah AA, Reyhanian A, Sarmast E

some small molecules absorb well

NNMT (nicotinamide N-methyltransferase) is the enzyme 5-Amino-1MQ inhibits, and tissue expression varies significantly across organs: adipose tissue shows 812 higher NNMT activity than skeletal muscle, which is why subcutaneous injection near adipose depots produces localised effects rodent models couldn't predict

2018, doi: 10.1016/S0140-6736(18)32260 Ceriello, S

Eligibility & Dose Requirements Proof of your current prescription and dosage is required during your consultation. Your provider will verify your eligibility and determine the appropriate dose based on your treatment history. To qualify for 4.4mg/week, you must have been prescribed at least 2.2mg/week within the past 45 days. To qualify for 7mg/week, you must have been prescribed at least 4.4mg/week within the past 45 days. To qualify for 10mg/week, you must have been prescribed at least 7mg/week within the past 45 days. Patients requesting 13mg/week must have documentation of prior treatment at an appropriate dose, as determined by the prescribing provider